Utah Retirement Systems’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,700
| Closed | -$305K | – | 953 |
|
|
2020
Q4 | $305K | Buy |
+5,700
| New | +$305K | ﹤0.01% | 856 |
|
|
2020
Q3 | – | Sell |
-4,600
| Closed | -$223K | – | 930 |
|
|
2020
Q2 | $223K | Buy |
+4,600
| New | +$223K | ﹤0.01% | 933 |
|
|
2018
Q2 | – | Sell |
-18,300
| Closed | -$411K | – | 996 |
|
|
2018
Q1 | $411K | Buy |
18,300
+100
| +0.5% | +$2.25K | 0.01% | 916 |
|
|
2017
Q4 | $548K | Buy |
18,200
+500
| +3% | +$15.1K | 0.01% | 888 |
|
|
2017
Q3 | $667K | Buy |
17,700
+100
| +0.6% | +$3.77K | 0.02% | 837 |
|
|
2017
Q2 | $491K | Buy |
17,600
+200
| +1% | +$5.58K | 0.01% | 908 |
|
|
2017
Q1 | $599K | Hold |
17,400
| – | – | 0.01% | 838 |
|
|
2016
Q4 | $502K | Hold |
17,400
| – | – | 0.01% | 868 |
|
|
2016
Q3 | $554K | Buy |
17,400
+1,000
| +6% | +$31.8K | 0.01% | 846 |
|
|
2016
Q2 | $532K | Buy |
+16,400
| New | +$532K | 0.01% | 846 |
|